Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Takeda Pharmaceutical Company Limited”

1,022 pharma patents match "Takeda Pharmaceutical Company Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,022
Index total 30,257
Page 12 / 43

Quick answer

This filtered view shows 1,022 pharmaceutical patents matching "Takeda Pharmaceutical Company Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,022 results for “Takeda Pharmaceutical Company Limited” · 30,257 patents in full index Clear search

  1. US 10689373

    1,2-substituted cyclopentanes as orexin receptor antagonists

    Takeda Pharmaceutical Company Limited · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  2. US 10676461

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  3. US 10676473

    Solid state forms of fused heteroaromatic pyrrolidinones

    Takeda Pharmaceutical Company Limited · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  4. US 10668260

    Microneedle patch

    Takeda Pharmaceutical Company Limited · Granted Jun 2, 2020 · Expires May 28, 2040

    granted
  5. US 10654874

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted May 19, 2020 · Expires May 14, 2040

    granted
  6. US 10610520

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Apr 7, 2020 · Expires Apr 2, 2040

    granted
  7. US 10597392

    Tetrahydropyridopyrazines as modulators of GPR6

    Takeda Pharmaceutical Company Limited · Granted Mar 24, 2020 · Expires Mar 19, 2040

    granted
  8. US 10584097

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted
  9. US 10577382

    Fused heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Mar 3, 2020 · Expires Feb 27, 2040

    granted
  10. US 10570091

    Method for producing pyrrole compound

    Takeda Pharmaceutical Company Limited · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  11. US 10561662

    4-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139

    Takeda Pharmaceutical Company Limited · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted
  12. US 10562882

    Piperidine derivatives for use in the treatment or prevention of psychiatric and neurological conditions

    Takeda Pharmaceutical Company Limited · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted
  13. US 10556256

    Antibacterial water

    Takeda Pharmaceutical Company Limited · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted
  14. US 10550129

    1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases

    Takeda Pharmaceutical Company Limited · Granted Feb 4, 2020 · Expires Jan 30, 2040

    granted
  15. US 10548899

    Quinazolinone and benzotriazinone compounds with cholinergic muscarinin M1 receptor positive allosteric modulator activity

    Takeda Pharmaceutical Company Limited · Granted Feb 4, 2020 · Expires Jan 30, 2040

    granted
  16. US 10548877

    Aromatic ring compound

    Takeda Pharmaceutical Company Limited · Granted Feb 4, 2020 · Expires Jan 30, 2040

    granted
  17. US 10544111

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted
  18. US 10544126

    Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases

    Takeda Pharmaceutical Company Limited · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted
  19. US 10519110

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted
  20. US 10508083

    Substituted piperidine compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Dec 17, 2019 · Expires Dec 12, 2039

    granted
  21. US 10501516

    Peptide compound

    Takeda Pharmaceutical Company Limited · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted
  22. US 10494444

    Anti-CD38 antibodies

    Takeda Pharmaceutical Company Limited · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted
  23. US 10472376

    Amide compound

    Takeda Pharmaceutical Company Limited · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted
  24. US 10463663

    Pyridazinone compounds and their use as DAAO inhibitors

    Takeda Pharmaceutical Company Limited · Granted Nov 5, 2019 · Expires Oct 31, 2039

    granted